Summary
- Current Price
- As of today, TRAX price is $38.60, down -1.53% on
- Current Price All-Time High
- TRAX price is currently -22.66% below its historical high of $49.91 set on
- Market Cap
- TRAX current market cap is $1B
- Revenue
- TRAX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for TRAX is on
Profile
| Metric | Value |
|---|---|
| Full Name | First Tracks Biotherapeutics, Inc. |
| Ticker | NASDAQ: TRAX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | firsttracksbio.com |
| Employees | 104 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $38.60 | |
| Price, 1D Change | -1.53% | |
| $1B | ||
| - | ||
| - | ||
| 3.13 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$4.76 | ||
| EPS, 1Y Change | -1.46% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | TRAXV | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$4.76 | ||
| EPS Estimate | -$4.10 | N/A |
| EPS Est. Change | +13.77% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $38.60 | |
| Price Target | $67.50 | - |
| Price Tgt. Change | +74.87% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$4.69 | - | |
| - | -$4.76 | - | |
| -$4.10 | N/A | +13.77% | |
| -$3.70 | N/A | +22.22% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $38.60 | |
| $28.72 | ||
| $41.47 | ||
| - | ||
| $38.42 | ||
| -$0.82 | ||
| 3.13 | ||
| $3.12 | ||
| 44.88 | ||
| 54.70% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$4.76 | ||
| -$2.42M | ||
| - | ||
| -$179.01M | ||
| - | ||
| -$166.09M | ||
| - | ||
| -$176.58M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.05 | ||
| 10.20 | ||
| 10.20 | ||
| - | ||
| - | ||
| 18.47 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 8.17 | ||
| -13.91 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $287.49M | ||
| $311.64M | ||
| $330.55M | ||
| $316.40M | ||
| $43.06M | ||
| $31.02M | ||
| $14.11M | ||
| $2.08M | ||
| $3.11M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $166.09M | ||
| $176.58M | ||
| $2.42M | ||
| $39.39M | ||
| $2.42M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$142.93M | ||
| $228.03M | ||
| $30.01M | ||
| $87.00K | ||
| -$143.01M |
Recent analyst updates
No data
Analyst sentiment
Institutional ownership
Screeners with TRAX
FAQ
- What is the ticker symbol for First Tracks Biotherapeutics, Inc.?
- The ticker symbol for First Tracks Biotherapeutics, Inc. is NASDAQ:TRAX
- Does First Tracks Biotherapeutics, Inc. pay dividends?
- No, First Tracks Biotherapeutics, Inc. does not pay dividends
- What sector is First Tracks Biotherapeutics, Inc. in?
- First Tracks Biotherapeutics, Inc. is in the Healthcare sector
- What industry is First Tracks Biotherapeutics, Inc. in?
- First Tracks Biotherapeutics, Inc. is in the Biotechnology industry
- What country is First Tracks Biotherapeutics, Inc. based in?
- First Tracks Biotherapeutics, Inc. is headquartered in United States
- When did First Tracks Biotherapeutics, Inc. go public?
- First Tracks Biotherapeutics, Inc. initial public offering (IPO) was on April 20, 2026
- Is First Tracks Biotherapeutics, Inc. in the S&P 500?
- No, First Tracks Biotherapeutics, Inc. is not included in the S&P 500 index
- Is First Tracks Biotherapeutics, Inc. in the NASDAQ 100?
- No, First Tracks Biotherapeutics, Inc. is not included in the NASDAQ 100 index
- Is First Tracks Biotherapeutics, Inc. in the Dow Jones?
- No, First Tracks Biotherapeutics, Inc. is not included in the Dow Jones index
- When was First Tracks Biotherapeutics, Inc. last earnings report?
- First Tracks Biotherapeutics, Inc.'s most recent earnings report was on August 14, 2026
- When does First Tracks Biotherapeutics, Inc. report earnings?
- The next expected earnings date for First Tracks Biotherapeutics, Inc. is November 5, 2026
Data Sources & References
- TRAX Official Website www.firsttracksbio.com
- TRAX Profile on Yahoo Finance finance.yahoo.com/quote/TRAX
- TRAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/trax